Sonnet Biotherapeutics Holdings Inc (SONN)
Official siteBIOTECHNOLOGY
Last updated: Dec 02, 2025 at 4:00 PM ET
Earnings
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 72.7% below its 50-day moving average. The 14-day RSI is 28.2, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about SONN
News
No news available
Company news will appear here when available
Sonnet Biotherapeutics Holdings Competitors
Peers by sector and size for Sonnet Biotherapeutics Holdings (SONN) include cbdMD, Biomx and Hoth Therapeutics.
Sector: Healthcare
SONN Earnings: Beat Rate
- Beat rate
- 5 of 8 quarters (62.5%)
- Average surprise
- -2.6%
SONN ETF Holders
GNG tracks 1 ETF that holds SONN.
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Dec 18, 2025. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About SONN
Does SONN pay dividends?
Sonnet Biotherapeutics Holdings Inc (SONN) does not currently pay a regular dividend.
SONN pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.